The Gastric Cancer Foundation: A Gastric Cancer Registry

This study has been terminated.
Sponsor:
Information provided by (Responsible Party):
Stanford University
ClinicalTrials.gov Identifier:
NCT01514045
First received: January 17, 2012
Last updated: June 22, 2016
Last verified: June 2016
  Purpose
The Gastric Cancer Registry will combine data acquired directly from patients with gastric cancer via an online questionnaire with genomic data obtained from blood and tissue samples. The purpose of this registry is to gain better understanding of the causes of gastric cancer, both environmental and genetic; whether certain genomic data can predict outcomes of treatment and survival; as well as explore the issues that effect the quality of life of these patients after diagnosis and treatment.

Condition
Gastric Cancer

Study Type: Observational
Study Design: Observational Model: Ecologic or Community
Time Perspective: Cross-Sectional
Official Title: The Gastric Cancer Foundation: A Gastric Cancer Registry

Resource links provided by NLM:


Further study details as provided by Stanford University:

Primary Outcome Measures:
  • Collect detailed clinical and epidemiological information on patients with gastric tumors [ Time Frame: A quality of life questionnaire will also be administered when patients first enroll in the registry and then every 6 months after for five years. Specimen collected once. ] [ Designated as safety issue: No ]

Biospecimen Retention:   Samples With DNA
Blood samples with DNA Paraffin embedded tissue will be stored in the Stanford Tissue Bank for 100 years.

Enrollment: 181
Study Start Date: April 2011
Study Completion Date: February 2015
Primary Completion Date: February 2015 (Final data collection date for primary outcome measure)
Detailed Description:
Collect detailed clinical and epidemiological information on patients with gastric tumors via an online registry and a detailed patient questionnaire. Participants can opt in to contribute a blood sample and paraffin block samples from previous surgery.
  Eligibility

Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Participants will be identified for recruitment either by the individual's treating physician or through information about the registry on the Gastric Cancer Fund website. Potential participants will be directed to the URL for the gastric cancer registry and asked to complete a brief registration form which will include eligibility questions.
Criteria

Inclusion Criteria:

  1. Patients are eligible if they have a histologically proven gastric tumor including gastroesophageal tumors
  2. 18 years of age or older
  3. Adequate English proficiency to complete online consent and questionnaire.

Exclusion Criteria:

  1. Under 18 years of age
  2. No history of gastric cancer or gastric cancer in a family member.
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01514045

Locations
United States, California
Stanford University Cancer Institute
Stanford, California, United States, 94305
Sponsors and Collaborators
Stanford University
Investigators
Principal Investigator: James M Ford, MD Stanford University
  More Information

Responsible Party: Stanford University
ClinicalTrials.gov Identifier: NCT01514045     History of Changes
Other Study ID Numbers: GI0005  SU-01172012-8987  20285 
Study First Received: January 17, 2012
Last Updated: June 22, 2016
Health Authority: United States: Food and Drug Administration

Keywords provided by Stanford University:
Quality of Life

Additional relevant MeSH terms:
Stomach Neoplasms
Gastrointestinal Neoplasms
Digestive System Neoplasms
Neoplasms by Site
Neoplasms
Digestive System Diseases
Gastrointestinal Diseases
Stomach Diseases

ClinicalTrials.gov processed this record on August 25, 2016